A detailed history of Prosperity Wealth Management, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Prosperity Wealth Management, Inc. holds 1,427 shares of VRTX stock, worth $643,534. This represents 0.27% of its overall portfolio holdings.

Number of Shares
1,427
Previous 1,242 14.9%
Holding current value
$643,534
Previous $582 Million 14.0%
% of portfolio
0.27%
Previous 0.29%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$460.0 - $505.78 $85,100 - $93,569
185 Added 14.9%
1,427 $664 Million
Q2 2024

Aug 13, 2024

BUY
$392.81 - $485.53 $487,870 - $603,028
1,242 New
1,242 $582 Million
Q2 2023

Sep 12, 2023

BUY
$314.42 - $351.91 $36,158 - $40,469
115 Added 15.54%
855 $301 Million
Q1 2023

Sep 12, 2023

BUY
$283.23 - $323.1 $209,590 - $239,094
740 New
740 $233 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Prosperity Wealth Management, Inc. Portfolio

Follow Prosperity Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosperity Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Prosperity Wealth Management, Inc. with notifications on news.